That accelerates
every stage of your
clinical trials
Aika isn't another black-box AI. It's clinical intelligence designed by people who've actually run trials.
Operational impact analysis
Operational
impact analysis
The Old Way
Protocol first draft
Protocol first draft
Complete protocol
(submission ready)
Complete protocol
(submission ready)
Amendments per trial
Amendments per trial
Cost per amendment
Cost per amendment
Feasibility timeline
Feasibility timeline
Success rate
Success rate
Success
rate
Annual impact
(10 trials/year)
Annual impact
(10 trials
/year)
The old way
The
Old Way
Up to 3 weeks
Up to
3 weeks
Up to 12 weeks
Up to
12 weeks
Avg. 3.3
Avg. 3.3
Up to $450K
Up to $450K
Up to 4 weeks
Up to 4 weeks
High regulatory uncertainty
High regulatory
uncertainty
High regulatory uncertainty
Status quo
(delays + amendments)
Status quo (delays + amendments)
With Aika
With
Aika
Up to 3 days
Up to
3 days
Up to 4 weeks
Up to
4 weeks
Down to 1.5 or fewer
Down to 1.5 or fewer
Minimized
Minimized
Less than 1 day
Less than
1 day
0 regulatory rejections
0 regulatory
rejections
0 regulatory rejections
Scalable &
predictable operations
Scalable &
predictable operations
Your
Savings
Your
Savings
Your savings
Your savings
90% faster
90%
faster
8 weeks saved
8 weeks
saved
~50% reduction
~50%
reduction
$400K avg saved
per amendment
$400K avg
saved per
amendment
3+ weeks saved
3+ weeks
saved
100% defensible
100%
defensible
100%
defensible
$1.2M - $2.4M*
(*mid-sized pipeline)
$1.2M - $2.4M*
(*mid-sized
pipeline)
GxP-compliant
GxP-compliant
|
|
SOC2 Type II
SOC2 Type II
|
|
HIPAA-ready
HIPAA-ready
The new standard
Finally, AI you can
actually explain
Step 1
Step 1
Step 1
Define your goals
Define your
goals
Input requirements in natural language or upload documents.
Input requirements in natural language or upload documents.
Step 2
Step 2
Step 2
Aika analyzes precedent
Cross-referencing ~1 million trials for proven patterns
Cross-referencing ~1 million trials for proven patterns
Step 3
Step 3
Step 3
Explainable recommendations
Explainable
recommendations
Citations and logic provided for every suggestion.
Citations and logic provided for every suggestion.
Step 4
Step 4
Step 4
Expert validation
Expert
validation
You maintain full control. Aika drafts, you decide.
You maintain full
control. Aika drafts, you decide.
Testimonials
Trusted by Leaders. Backed by Science.
Based on ~1 million real trials.
“Biorce is exactly the kind of pioneering company we’re here to back. They’re combining deep sector expertise with cutting-edge AI to solve what truly matters. Their platform has the potential to radically reduce both the time and cost of bringing new treatments to market, unlocking huge value for pharma and, more importantly, faster access to life-saving therapies for patients.”
Tove Larsson
General Partner | Norrsken VC
Used across US, EU & APAC by global clinical trial teams.
"The expansive potential of Jarvis hints at a wealth of untapped applications beyond drugs development; it opens the door to evolutionary possibilities that could help redefine efficiency and precision in the broader medical field"
Ricardo Matias
CRIO | Co-Founder of Kinetikos
Built by former CRO, clinicians, regulatory, and AI leaders.
$5M invested by Norrsken, Europe’s leading impact VC to reinvent clinical trials.
"I think this is a fantastic tool for clinical trialists that will not only save time but could potentially reduce the number of avoidable protocol amendments, saving costs and enhancing confidence in evaluation of the study objectives"
Laurence Skillern
Medical Director | CMO of ISTESSO
Trusted by Leaders. Backed by Science.
Based on ~1 million real trials.
“Biorce is exactly the kind of pioneering company we’re here to back. They’re combining deep sector expertise with cutting-edge AI to solve what truly matters. Their platform has the potential to radically reduce both the time and cost of bringing new treatments to market, unlocking huge value for pharma and, more importantly, faster access to life-saving therapies for patients.”
Tove Larsson
General Partner | Norrsken VC
Used across US, EU & APAC by global clinical trial teams.
"The expansive potential of Jarvis hints at a wealth of untapped applications beyond drugs development; it opens the door to evolutionary possibilities that could help redefine efficiency and precision in the broader medical field"
Ricardo Matias
CRIO | Co-Founder of Kinetikos
Built by former CRO, clinicians, regulatory, and AI leaders.
$5M invested by Norrsken, Europe’s leading impact VC to reinvent clinical trials.
"I think this is a fantastic tool for clinical trialists that will not only save time but could potentially reduce the number of avoidable protocol amendments, saving costs and enhancing confidence in evaluation of the study objectives"
Laurence Skillern
Medical Director | CMO of ISTESSO
Proven impact: Phase II Oncology
Proven impact: Phase II Oncology
Proven impact:
Phase II Oncology
How a top-tier Pharma eliminated
3 amendments and saved $1.2M
How a top-tier Pharma eliminated 3 amendments and saved $1.2M
Read the full Case Study
Read the full Case Study
Read the full Case Study
No email required
No email required
